US COPD Coalition

USCC Supports PCORI Re-Authorization in Letter to Congress


The US COPD Coalition has signed on to a letter to the Chairs and Ranking Members of the House Ways & Means Committee, the House Committee on Energy and Commerce, and the Senate Finance committee urging re-authorization of the Patient-Centered Outcomes Research Institute (PCORI). The letter addresses the important role PCORI plays in clinical research. “Our health care system requires solutions that are both evidence-based and patient-centered, to improve care while also addressing health care spending. PCORI is uniquely set up to meet this challenge, as it is the only organization dedicated to funding comparative clinical effectiveness research (CER) studies comparing which treatment approaches work best, for which patients, given their needs and preferences.”

As of December 2018, PCORI has awarded more than $2.4 billion in grants to more than 600 research-related projects in 44 states across the United States. PCORI’s stated vision is to “help people make informed healthcare decisions, and improves healthcare delivery and outcomes, by producing and promoting high-integrity, evidence-based information that comes from research guided by patients, caregivers, and the broader healthcare community.” The US COPD Coalition supports that vision.

Click the links below to view the letters sent to Congress.
PCORI Reauthorization Letter – House
PCORI Reauthorization Letter – Senate